desk
Share
News Topical, Digital Desk : Dr Reddys, a pharma company listed on BSE 100, has released its March quarter results. The company's profit has increased by 22 percent compared to last year. The income has increased by 9 percent on a year-on-year basis. EBITDA has increased by 59 percent compared to last year. Margins have also improved. The company's results have been much better than the estimates received in CNBC TV18's poll. Along with the results, the company has also announced a final dividend of Rs 8 per share.
The company's results came after the market closed on Friday. In today's trading, Dr. Reddy's Lab's stock closed at 1156.7 with a gain of about 0.7 percent.
How were the quarterly results? The company's consolidated profit has increased from Rs 1,307 crore to Rs 1,594 crore as compared to last year. It has seen a growth of 22 percent on a year-on-year basis. The profit has been higher than the market's estimate. In the CNBC TV 18 poll, a profit of Rs 1491.6 crore was estimated. The company's consolidated income has increased from Rs 7,830 crore to Rs 8,506 crore. It has seen a growth of 8.6 percent on a year-on-year basis. The figure has been better than the estimate. The poll showed Rs 8404.7 crore. The company's EBITDA has increased from Rs 1,872 crore to Rs 2,975 crore. It has seen a growth of 58.9 percent. The poll has given an estimate of EBITDA of Rs 2,323.7 crore. EBITDA margin has increased from 24 percent to 29.1 percent compared to last year. The market had estimated a margin of 28 percent.
--Advertisement--
